Total Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases Such as Ebola Disease

Total Investment of Approx. USD 6.8 Million in Product Development for Malaria, NTDs and Other Emerging & Re-emerging Infectious Diseases Such as Ebola Disease

TOKYO, Oct. 29, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.06 billion (USD 6.8 million1) in nine R&D projects for the development of drugs, vaccines and...

LEIFRAS Co., Ltd. Re-selected to Provide Swimming Lesson Support for 1,757 Sessions Across 43 Schools in Fukuoka City

LEIFRAS Co., Ltd. Re-selected to Provide Swimming Lesson Support for 1,757 Sessions Across 43 Schools in Fukuoka City

Physical Education Class Support Initiative Aims to Further Reduce Teacher Workloads TOKYO, May 12, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and...

menu
menu